Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine
Clinical trial NCT03739229 · UNKNOWN
Trial details
- NCT number
- NCT03739229
- Sponsor
- Research Institute of Influenza, Russia
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2019-06-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.